US equities
|
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
NVDA
$210.96
▲+0.00%
AAPL
$347.73
▲+0.00%
NU
$15.16
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SPCX
$147.49
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
NVDA
$210.96
▲+0.00%
AAPL
$347.73
▲+0.00%
NU
$15.16
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:IKT
Recent news which mentions NASDAQ:IKT
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024
August 14, 2024
Tickers
IKT
Tags
Earnings Reports
Market News
IKT
From
InvestorPlace
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q1 2024
May 16, 2024
Tickers
IKT
Tags
Earnings Reports
Market News
IKT
From
InvestorPlace
IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q4 2023
March 27, 2024
Tickers
IKT
Tags
Market News
IKT
NASDAQ:IKT
From
InvestorPlace
Inhibikase Therapeutics: A Novel And Promising Approach To Neurodegeneration And Oncology
May 24, 2023
Tags
NASDAQ:IKT
From
News Direct